#234 | Could This Be a New Route to Market for MedTech in the NHS?

What if there were a clearer route for taking your MedTech product from NHS evaluation to adoption and wider scale?

Getting your MedTech product successfully evaluated in the NHS doesn't automatically create a route to market. The harder challenge is turning that evidence into procurement, funding, routine adoption and eventually wider NHS scale. In this episode, Hakeem explores the newly announced Manchester Sandbox, why its ambition could help bridge this commercialisation gap, and the questions that still need answering.

In this episode you'll discover:

What the Manchester Sandbox is and why MedTech companies looking to enter or grow within the NHS should be paying attention.How its ambition to connect real-world NHS evaluation with adoption could potentially create a clearer route to market for promising medical technologies.What still needs to happen after a successful evaluation if the Sandbox is going to help MedTech companies move beyond one NHS Trust and achieve wider adoption and scale.

Listen now to discover whether the Manchester Sandbox could create a clearer route to market for MedTech companies trying to turn successful NHS evaluations into adoption and wider scale.

Book a 30min Healthcare Export Accelerator discovery call

Message me via DM on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.